Healthcare professionals' views of the use of oral morphine and transmucosal diamorphine in the management of paediatric breakthrough pain and the feasibility of a randomised controlled trial: A focus group study (DIPPER).

Liz JamiesonEmily HarropMargaret JohnsonChristina Liossi Christine MottKate OultonSimon S SkeneIan Ck WongRichard F Howard

Published in: Palliative medicine (2021)

There were perceived advantages to transmucosal diamorphine, but there is a need for access to a safe preparation. A clinical trial would be feasible provided barriers were overcome.

Keyphrases

clinical trial
chronic pain
social support
pain management
depressive symptoms
intensive care unit
emergency department
neuropathic pain
physical activity
mental health
phase ii
open label
double blind
spinal cord injury
postoperative pain